Ann Arbor, MI, United States of America

Ronald J Buckanovich

This inventor holds 5 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: University of Michigan, University of Pennsylvania, Indiana University. Active years: 2016-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald J Buckanovich. Retrieved from https://idiyas.com/inventor/ronald-j-buckanovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0


Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ronald J. Buckanovich: Innovator in Cancer Treatment

Introduction

Ronald J. Buckanovich, located in Ann Arbor, Michigan, is a distinguished inventor with a significant impact in the field of medicinal chemistry. With five patented inventions, he has contributed valuable knowledge and solutions for cancer treatment and immunotherapy. His work exemplifies the intersection of innovative research and practical applications in healthcare.

Latest Patents

Ronald J. Buckanovich holds several recent patents that showcase his expertise in medicinal chemistry. One of his latest innovations is titled "Small molecule inhibitors of ALDH and uses thereof." This invention introduces a new class of small molecules with a thiopyrimidinone structure, functioning as inhibitors of the ALDH protein. These molecules hold therapeutic potential for treating cancer and other diseases.

Another important patent from Buckanovich is "Methods and compositions for treating solid tumors and enhancing tumor vaccines." This invention outlines methods for treating solid tumors and improving the efficacy of immunotherapy. It involves contacting subjects with compounds that modulate the expression or activity of specific proteins, ultimately aimed at enhancing T cell homing to tumors. These methods also include prognosticating solid tumors through measuring the expression level of proteins that play a crucial role in T cell targeting.

Career Highlights

Throughout his career, Ronald J. Buckanovich has held significant positions at reputable institutions such as the University of Michigan and the University of Pennsylvania. His research centers on expanding the boundaries of cancer therapies and developing novel treatment methodologies.

Collaborations

In his journey of innovation, Buckanovich has collaborated with esteemed colleagues, including George Coukos and Andrea Facciabene. These partnerships highlight the collaborative nature of research and the exchange of ideas vital for pioneering advancements in medical science.

Conclusion

Ronald J. Buckanovich stands out as a notable inventor in the realm of cancer treatment and immunotherapy. With a solid portfolio of patents and valuable collaborations, he continues to contribute to the field of medicinal chemistry, paving the way for future innovations that promise to enhance therapeutic outcomes for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…